The University of Maryland MIPS Program announced that our client, Plasmonix, has been awarded a MIPs project, which teams companies with universities across the state to focus on advancing commercially promising technologies into the marketplace.
“The MIPS award is a critical component of Plasmonix’s product development and introduction plans. The award is hugely important to the Company’s ability to hit the ground running as we enter 2013.” Says William Gust, President and Chief Executive who has raised $1.5 million for Baltimore-based Plasmonix.
Plasmonix was also selected to present at the upcoming Mid Atlantic Bio Conference on September 27th and 28th.